Zheng Zhang, Wei Fan, Gui Yang, Zhigao Xu, June Wang, Qingyuan Cheng Mingxia Yu. Risk of tuberculosis in patient treated with TNF-alfa antagonist: a systematic review and meta-analysis of randomised controlled trials. 2017 Mar 22; 7(3): e012567. doi: 10.1

J Keane, S Gershon, R P Wise, E Mirabile-Levens, J Kasznica, W D Schwieterman, J N Siegel, M M Braun. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001 Oct 11; 345 (15): 1098–104. doi: 10.1056/ N

Schlovinck E, Wilkinson KA, Whelan AO, et al. Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme linked immunospot methods. J Clin Microbiol 2004; 42: 829–31.

Snowden FM. Emerging and reemerging diseases: a historical perspective.

Uplekar M, Weil D, Lonnroth K, Jaramilo E, Leinhardt C, Dias HM, et al. WHO s new end TB strategy. Lancet. 2015; 385(9979): 1799–801.

Latentna tuberkuloza – smernice za dijagnostiku latentne tuberkuloze sa primerima iz kliničke prakse. Klinika za pulmologiju Kliničkog centra Srbije, Respiratorno udruženje Srbije, Beograd, 2019.